nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—Zalcitabine—Gemcitabine—kidney cancer	0.434	1	CrCrCtD
Didanosine—SLC29A2—Gemcitabine—kidney cancer	0.259	0.635	CbGbCtD
Didanosine—SLC29A1—Gemcitabine—kidney cancer	0.149	0.365	CbGbCtD
Didanosine—PNP—Purine salvage—APRT—kidney cancer	0.0078	0.257	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—PPAT—kidney cancer	0.00398	0.131	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—APRT—kidney cancer	0.0037	0.122	CbGpPWpGaD
Didanosine—PNP—renal system—kidney cancer	0.00267	0.187	CbGeAlD
Didanosine—PNP—kidney—kidney cancer	0.00259	0.181	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00209	0.069	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—PPAT—kidney cancer	0.002	0.066	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—APRT—kidney cancer	0.00186	0.0614	CbGpPWpGaD
Didanosine—SLC29A2—cardiac atrium—kidney cancer	0.0018	0.126	CbGeAlD
Didanosine—SLC22A6—nephron tubule—kidney cancer	0.00137	0.096	CbGeAlD
Didanosine—SLC22A6—cortex of kidney—kidney cancer	0.00117	0.0821	CbGeAlD
Didanosine—SLC29A1—renal system—kidney cancer	0.000996	0.0697	CbGeAlD
Didanosine—SLC29A1—kidney—kidney cancer	0.000963	0.0674	CbGeAlD
Didanosine—SLC29A1—cortex of kidney—kidney cancer	0.000938	0.0657	CbGeAlD
Didanosine—SLC29A1—gonad—kidney cancer	0.000893	0.0625	CbGeAlD
Didanosine—SLC29A1—cardiac atrium—kidney cancer	0.000892	0.0624	CbGeAlD
Didanosine—PNP—Sirolimus—Temsirolimus—kidney cancer	0.000755	0.232	CbGdCrCtD
Didanosine—PNP—Temsirolimus—Everolimus—kidney cancer	0.000755	0.232	CbGdCrCtD
Didanosine—PNP—Sirolimus—Everolimus—kidney cancer	0.000755	0.232	CbGdCrCtD
Didanosine—PNP—Gefitinib—Erlotinib—kidney cancer	0.000753	0.231	CbGdCrCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000438	0.0145	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000388	0.0128	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000304	0.01	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000269	0.00887	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000267	0.00882	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACY1—kidney cancer	0.000262	0.00865	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—kidney cancer	0.000243	0.0746	CbGdCrCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000231	0.00763	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000223	0.00737	CbGpPWpGaD
Didanosine—PNP—Metabolism—PDHB—kidney cancer	0.000223	0.00736	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000223	0.00735	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000223	0.00735	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000223	0.00735	CbGpPWpGaD
Didanosine—PNP—Metabolism—CCBL1—kidney cancer	0.00021	0.00692	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—kidney cancer	0.000208	0.00685	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPAT—kidney cancer	0.000182	0.006	CbGpPWpGaD
Didanosine—PNP—Metabolism—GLIPR1—kidney cancer	0.000182	0.006	CbGpPWpGaD
Didanosine—PNP—Metabolism—FH—kidney cancer	0.000169	0.00557	CbGpPWpGaD
Didanosine—PNP—Metabolism—APRT—kidney cancer	0.000169	0.00557	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.00016	0.00529	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPC3—kidney cancer	0.000159	0.00524	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000155	0.00511	CbGpPWpGaD
Didanosine—PNP—Metabolism—CA2—kidney cancer	0.000154	0.0051	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000154	0.0051	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000154	0.0051	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000154	0.0051	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALAD—kidney cancer	0.000151	0.00497	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000148	0.00135	CcSEcCtD
Didanosine—Thrombocytopenia—Sunitinib—kidney cancer	0.000148	0.00135	CcSEcCtD
Didanosine—Gastrointestinal pain—Everolimus—kidney cancer	0.000148	0.00135	CcSEcCtD
Didanosine—Discomfort—Dactinomycin—kidney cancer	0.000147	0.00134	CcSEcCtD
Didanosine—PNP—Metabolism—ST3GAL2—kidney cancer	0.000147	0.00485	CbGpPWpGaD
Didanosine—Vomiting—Pazopanib—kidney cancer	0.000145	0.00133	CcSEcCtD
Didanosine—Anaemia—Vincristine—kidney cancer	0.000145	0.00132	CcSEcCtD
Didanosine—Rash—Pazopanib—kidney cancer	0.000144	0.00132	CcSEcCtD
Didanosine—Nausea—Temsirolimus—kidney cancer	0.000144	0.00132	CcSEcCtD
Didanosine—Dermatitis—Pazopanib—kidney cancer	0.000144	0.00132	CcSEcCtD
Didanosine—Anorexia—Sunitinib—kidney cancer	0.000144	0.00131	CcSEcCtD
Didanosine—PNP—Metabolism—ALDH1A1—kidney cancer	0.000144	0.00474	CbGpPWpGaD
Didanosine—Abdominal pain—Vinblastine—kidney cancer	0.000143	0.00131	CcSEcCtD
Didanosine—Headache—Pazopanib—kidney cancer	0.000143	0.00131	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000143	0.0013	CcSEcCtD
Didanosine—Body temperature increased—Everolimus—kidney cancer	0.000143	0.0013	CcSEcCtD
Didanosine—Abdominal pain—Everolimus—kidney cancer	0.000143	0.0013	CcSEcCtD
Didanosine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000143	0.0013	CcSEcCtD
Didanosine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000142	0.0013	CcSEcCtD
Didanosine—Infection—Dactinomycin—kidney cancer	0.000142	0.0013	CcSEcCtD
Didanosine—Neuropathy—Doxorubicin—kidney cancer	0.000141	0.00129	CcSEcCtD
Didanosine—Leukopenia—Vincristine—kidney cancer	0.00014	0.00128	CcSEcCtD
Didanosine—Thrombocytopenia—Dactinomycin—kidney cancer	0.00014	0.00128	CcSEcCtD
Didanosine—Dry eye—Doxorubicin—kidney cancer	0.000139	0.00127	CcSEcCtD
Didanosine—Dyspepsia—Sorafenib—kidney cancer	0.000138	0.00126	CcSEcCtD
Didanosine—Abdominal pain—Erlotinib—kidney cancer	0.000138	0.00126	CcSEcCtD
Didanosine—Body temperature increased—Erlotinib—kidney cancer	0.000138	0.00126	CcSEcCtD
Didanosine—PNP—Metabolism—PGK1—kidney cancer	0.000138	0.00454	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC5A3—kidney cancer	0.000138	0.00454	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000137	0.00125	CcSEcCtD
Didanosine—Anaemia—Gemcitabine—kidney cancer	0.000137	0.00125	CcSEcCtD
Didanosine—Decreased appetite—Sorafenib—kidney cancer	0.000136	0.00124	CcSEcCtD
Didanosine—Anorexia—Dactinomycin—kidney cancer	0.000136	0.00124	CcSEcCtD
Didanosine—Nausea—Pazopanib—kidney cancer	0.000136	0.00124	CcSEcCtD
Didanosine—Paraesthesia—Sunitinib—kidney cancer	0.000135	0.00124	CcSEcCtD
Didanosine—PNP—Metabolism—LDHB—kidney cancer	0.000135	0.00446	CbGpPWpGaD
Didanosine—Pain—Sorafenib—kidney cancer	0.000134	0.00122	CcSEcCtD
Didanosine—Malaise—Gemcitabine—kidney cancer	0.000134	0.00122	CcSEcCtD
Didanosine—Hypersensitivity—Vinblastine—kidney cancer	0.000134	0.00122	CcSEcCtD
Didanosine—Myalgia—Vincristine—kidney cancer	0.000133	0.00122	CcSEcCtD
Didanosine—Hypersensitivity—Everolimus—kidney cancer	0.000133	0.00121	CcSEcCtD
Didanosine—Dyspepsia—Sunitinib—kidney cancer	0.000133	0.00121	CcSEcCtD
Didanosine—Leukopenia—Gemcitabine—kidney cancer	0.000133	0.00121	CcSEcCtD
Didanosine—Hyperglycaemia—Capecitabine—kidney cancer	0.000132	0.0012	CcSEcCtD
Didanosine—Decreased appetite—Sunitinib—kidney cancer	0.000131	0.0012	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00013	0.00119	CcSEcCtD
Didanosine—Asthenia—Vinblastine—kidney cancer	0.00013	0.00119	CcSEcCtD
Didanosine—Asthenia—Everolimus—kidney cancer	0.00013	0.00118	CcSEcCtD
Didanosine—Pain—Sunitinib—kidney cancer	0.000129	0.00118	CcSEcCtD
Didanosine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000128	0.00117	CcSEcCtD
Didanosine—Chills—Paclitaxel—kidney cancer	0.000128	0.00117	CcSEcCtD
Didanosine—Neuropathy peripheral—Capecitabine—kidney cancer	0.000128	0.00117	CcSEcCtD
Didanosine—Pruritus—Everolimus—kidney cancer	0.000128	0.00117	CcSEcCtD
Didanosine—Anaphylactic shock—Vincristine—kidney cancer	0.000128	0.00117	CcSEcCtD
Didanosine—Infection—Vincristine—kidney cancer	0.000127	0.00116	CcSEcCtD
Didanosine—Myalgia—Gemcitabine—kidney cancer	0.000126	0.00115	CcSEcCtD
Didanosine—Arthralgia—Gemcitabine—kidney cancer	0.000126	0.00115	CcSEcCtD
Didanosine—Alopecia—Paclitaxel—kidney cancer	0.000126	0.00115	CcSEcCtD
Didanosine—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000125	0.00115	CcSEcCtD
Didanosine—Diabetes mellitus—Doxorubicin—kidney cancer	0.000125	0.00115	CcSEcCtD
Didanosine—Asthenia—Erlotinib—kidney cancer	0.000125	0.00114	CcSEcCtD
Didanosine—Thrombocytopenia—Vincristine—kidney cancer	0.000125	0.00114	CcSEcCtD
Didanosine—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000125	0.00114	CcSEcCtD
Didanosine—Discomfort—Gemcitabine—kidney cancer	0.000125	0.00114	CcSEcCtD
Didanosine—Decreased appetite—Dactinomycin—kidney cancer	0.000124	0.00113	CcSEcCtD
Didanosine—Diarrhoea—Vinblastine—kidney cancer	0.000124	0.00113	CcSEcCtD
Didanosine—Body temperature increased—Sorafenib—kidney cancer	0.000124	0.00113	CcSEcCtD
Didanosine—Abdominal pain—Sorafenib—kidney cancer	0.000124	0.00113	CcSEcCtD
Didanosine—Diarrhoea—Everolimus—kidney cancer	0.000124	0.00113	CcSEcCtD
Didanosine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000123	0.00113	CcSEcCtD
Didanosine—Hepatobiliary disease—Capecitabine—kidney cancer	0.000123	0.00113	CcSEcCtD
Didanosine—Pruritus—Erlotinib—kidney cancer	0.000123	0.00113	CcSEcCtD
Didanosine—Flatulence—Paclitaxel—kidney cancer	0.000122	0.00112	CcSEcCtD
Didanosine—Pain—Dactinomycin—kidney cancer	0.000122	0.00112	CcSEcCtD
Didanosine—Agranulocytosis—Capecitabine—kidney cancer	0.000122	0.00111	CcSEcCtD
Didanosine—Anorexia—Vincristine—kidney cancer	0.000122	0.00111	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000121	0.00401	CbGpPWpGaD
Didanosine—Hepatic failure—Doxorubicin—kidney cancer	0.000121	0.00111	CcSEcCtD
Didanosine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000121	0.00111	CcSEcCtD
Didanosine—Infection—Gemcitabine—kidney cancer	0.00012	0.0011	CcSEcCtD
Didanosine—Body temperature increased—Sunitinib—kidney cancer	0.000119	0.00109	CcSEcCtD
Didanosine—Abdominal pain—Sunitinib—kidney cancer	0.000119	0.00109	CcSEcCtD
Didanosine—Diarrhoea—Erlotinib—kidney cancer	0.000119	0.00109	CcSEcCtD
Didanosine—Thrombocytopenia—Gemcitabine—kidney cancer	0.000119	0.00108	CcSEcCtD
Didanosine—Renal failure acute—Doxorubicin—kidney cancer	0.000118	0.00108	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000118	0.00388	CbGpPWpGaD
Didanosine—Hepatitis—Capecitabine—kidney cancer	0.000117	0.00107	CcSEcCtD
Didanosine—PNP—Metabolism—CA9—kidney cancer	0.000117	0.00386	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000117	0.00107	CcSEcCtD
Didanosine—Hypoaesthesia—Capecitabine—kidney cancer	0.000117	0.00106	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000116	0.00106	CcSEcCtD
Didanosine—Hypersensitivity—Sorafenib—kidney cancer	0.000116	0.00105	CcSEcCtD
Didanosine—Anorexia—Gemcitabine—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Vomiting—Vinblastine—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Vomiting—Everolimus—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Anaemia—Paclitaxel—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Renal impairment—Doxorubicin—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Paraesthesia—Vincristine—kidney cancer	0.000115	0.00105	CcSEcCtD
Didanosine—Rash—Everolimus—kidney cancer	0.000114	0.00104	CcSEcCtD
Didanosine—Dermatitis—Everolimus—kidney cancer	0.000114	0.00104	CcSEcCtD
Didanosine—Headache—Vinblastine—kidney cancer	0.000114	0.00104	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000113	0.00375	CbGpPWpGaD
Didanosine—Headache—Everolimus—kidney cancer	0.000113	0.00103	CcSEcCtD
Didanosine—Abdominal pain—Dactinomycin—kidney cancer	0.000113	0.00103	CcSEcCtD
Didanosine—Body temperature increased—Dactinomycin—kidney cancer	0.000113	0.00103	CcSEcCtD
Didanosine—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000113	0.00103	CcSEcCtD
Didanosine—Asthenia—Sorafenib—kidney cancer	0.000113	0.00103	CcSEcCtD
Didanosine—Malaise—Paclitaxel—kidney cancer	0.000112	0.00102	CcSEcCtD
Didanosine—Hypoglycaemia—Doxorubicin—kidney cancer	0.000112	0.00102	CcSEcCtD
Didanosine—Leukopenia—Paclitaxel—kidney cancer	0.000111	0.00101	CcSEcCtD
Didanosine—Hypersensitivity—Sunitinib—kidney cancer	0.000111	0.00101	CcSEcCtD
Didanosine—Decreased appetite—Vincristine—kidney cancer	0.000111	0.00101	CcSEcCtD
Didanosine—Pruritus—Sorafenib—kidney cancer	0.000111	0.00101	CcSEcCtD
Didanosine—Vomiting—Erlotinib—kidney cancer	0.000111	0.00101	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.00011	0.00101	CcSEcCtD
Didanosine—Rash—Erlotinib—kidney cancer	0.00011	0.001	CcSEcCtD
Didanosine—Dermatitis—Erlotinib—kidney cancer	0.00011	0.001	CcSEcCtD
Didanosine—Headache—Erlotinib—kidney cancer	0.000109	0.000997	CcSEcCtD
Didanosine—Pain—Vincristine—kidney cancer	0.000109	0.000996	CcSEcCtD
Didanosine—Paraesthesia—Gemcitabine—kidney cancer	0.000109	0.000992	CcSEcCtD
Didanosine—Asthenia—Sunitinib—kidney cancer	0.000108	0.000988	CcSEcCtD
Didanosine—Nausea—Vinblastine—kidney cancer	0.000108	0.000983	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000107	0.00355	CbGpPWpGaD
Didanosine—Nausea—Everolimus—kidney cancer	0.000107	0.00098	CcSEcCtD
Didanosine—Diarrhoea—Sorafenib—kidney cancer	0.000107	0.000979	CcSEcCtD
Didanosine—Pruritus—Sunitinib—kidney cancer	0.000107	0.000975	CcSEcCtD
Didanosine—Arthralgia—Paclitaxel—kidney cancer	0.000106	0.000965	CcSEcCtD
Didanosine—Myalgia—Paclitaxel—kidney cancer	0.000106	0.000965	CcSEcCtD
Didanosine—Decreased appetite—Gemcitabine—kidney cancer	0.000105	0.000961	CcSEcCtD
Didanosine—Hypersensitivity—Dactinomycin—kidney cancer	0.000105	0.000961	CcSEcCtD
Didanosine—Chills—Capecitabine—kidney cancer	0.000105	0.000959	CcSEcCtD
Didanosine—Discomfort—Paclitaxel—kidney cancer	0.000104	0.000954	CcSEcCtD
Didanosine—Gastrointestinal pain—Vincristine—kidney cancer	0.000104	0.000953	CcSEcCtD
Didanosine—Pain—Gemcitabine—kidney cancer	0.000104	0.000945	CcSEcCtD
Didanosine—Nausea—Erlotinib—kidney cancer	0.000104	0.000945	CcSEcCtD
Didanosine—Alopecia—Capecitabine—kidney cancer	0.000103	0.000945	CcSEcCtD
Didanosine—Dry mouth—Paclitaxel—kidney cancer	0.000103	0.000944	CcSEcCtD
Didanosine—Diarrhoea—Sunitinib—kidney cancer	0.000103	0.000942	CcSEcCtD
Didanosine—Asthenia—Dactinomycin—kidney cancer	0.000102	0.000936	CcSEcCtD
Didanosine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000101	0.000925	CcSEcCtD
Didanosine—Abdominal pain—Vincristine—kidney cancer	0.000101	0.000921	CcSEcCtD
Didanosine—Body temperature increased—Vincristine—kidney cancer	0.000101	0.000921	CcSEcCtD
Didanosine—Infection—Paclitaxel—kidney cancer	0.000101	0.000919	CcSEcCtD
Didanosine—Flatulence—Capecitabine—kidney cancer	0.0001	0.000917	CcSEcCtD
Didanosine—Vomiting—Sorafenib—kidney cancer	9.97e-05	0.00091	CcSEcCtD
Didanosine—Abdominal pain upper—Doxorubicin—kidney cancer	9.96e-05	0.00091	CcSEcCtD
Didanosine—PNP—Metabolism—CRABP1—kidney cancer	9.96e-05	0.00329	CbGpPWpGaD
Didanosine—Thrombocytopenia—Paclitaxel—kidney cancer	9.92e-05	0.000906	CcSEcCtD
Didanosine—Rash—Sorafenib—kidney cancer	9.89e-05	0.000903	CcSEcCtD
Didanosine—Dermatitis—Sorafenib—kidney cancer	9.88e-05	0.000902	CcSEcCtD
Didanosine—Headache—Sorafenib—kidney cancer	9.82e-05	0.000897	CcSEcCtD
Didanosine—Diarrhoea—Dactinomycin—kidney cancer	9.77e-05	0.000892	CcSEcCtD
Didanosine—Anorexia—Paclitaxel—kidney cancer	9.66e-05	0.000882	CcSEcCtD
Didanosine—Vomiting—Sunitinib—kidney cancer	9.59e-05	0.000876	CcSEcCtD
Didanosine—Body temperature increased—Gemcitabine—kidney cancer	9.57e-05	0.000874	CcSEcCtD
Didanosine—Rash—Sunitinib—kidney cancer	9.51e-05	0.000868	CcSEcCtD
Didanosine—Dermatitis—Sunitinib—kidney cancer	9.51e-05	0.000868	CcSEcCtD
Didanosine—Headache—Sunitinib—kidney cancer	9.45e-05	0.000863	CcSEcCtD
Didanosine—Anaemia—Capecitabine—kidney cancer	9.42e-05	0.00086	CcSEcCtD
Didanosine—Hypersensitivity—Vincristine—kidney cancer	9.4e-05	0.000858	CcSEcCtD
Didanosine—Nausea—Sorafenib—kidney cancer	9.31e-05	0.00085	CcSEcCtD
Didanosine—PNP—Metabolism—ITPR2—kidney cancer	9.26e-05	0.00305	CbGpPWpGaD
Didanosine—Pancreatitis—Doxorubicin—kidney cancer	9.24e-05	0.000844	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	9.24e-05	0.000843	CcSEcCtD
Didanosine—Malaise—Capecitabine—kidney cancer	9.19e-05	0.000839	CcSEcCtD
Didanosine—Asthenia—Vincristine—kidney cancer	9.16e-05	0.000836	CcSEcCtD
Didanosine—Leukopenia—Capecitabine—kidney cancer	9.12e-05	0.000833	CcSEcCtD
Didanosine—Paraesthesia—Paclitaxel—kidney cancer	9.1e-05	0.000831	CcSEcCtD
Didanosine—Vomiting—Dactinomycin—kidney cancer	9.08e-05	0.000829	CcSEcCtD
Didanosine—Rash—Dactinomycin—kidney cancer	9.01e-05	0.000822	CcSEcCtD
Didanosine—Nausea—Sunitinib—kidney cancer	8.96e-05	0.000818	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.96e-05	0.00296	CbGpPWpGaD
Didanosine—Dyspepsia—Paclitaxel—kidney cancer	8.92e-05	0.000815	CcSEcCtD
Didanosine—Decreased appetite—Paclitaxel—kidney cancer	8.81e-05	0.000804	CcSEcCtD
Didanosine—Diarrhoea—Vincristine—kidney cancer	8.73e-05	0.000797	CcSEcCtD
Didanosine—Asthenia—Gemcitabine—kidney cancer	8.69e-05	0.000793	CcSEcCtD
Didanosine—Myalgia—Capecitabine—kidney cancer	8.68e-05	0.000792	CcSEcCtD
Didanosine—Arthralgia—Capecitabine—kidney cancer	8.68e-05	0.000792	CcSEcCtD
Didanosine—Pain—Paclitaxel—kidney cancer	8.67e-05	0.000791	CcSEcCtD
Didanosine—Discomfort—Capecitabine—kidney cancer	8.57e-05	0.000783	CcSEcCtD
Didanosine—Pruritus—Gemcitabine—kidney cancer	8.57e-05	0.000782	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—kidney cancer	8.51e-05	0.000776	CcSEcCtD
Didanosine—Dry mouth—Capecitabine—kidney cancer	8.49e-05	0.000775	CcSEcCtD
Didanosine—Nausea—Dactinomycin—kidney cancer	8.48e-05	0.000775	CcSEcCtD
Didanosine—PNP—Metabolism—GSTT1—kidney cancer	8.44e-05	0.00279	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACHE—kidney cancer	8.44e-05	0.00279	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Paclitaxel—kidney cancer	8.29e-05	0.000757	CcSEcCtD
Didanosine—Diarrhoea—Gemcitabine—kidney cancer	8.28e-05	0.000756	CcSEcCtD
Didanosine—Infection—Capecitabine—kidney cancer	8.26e-05	0.000754	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—kidney cancer	8.24e-05	0.000752	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.15e-05	0.00269	CbGpPWpGaD
Didanosine—Thrombocytopenia—Capecitabine—kidney cancer	8.14e-05	0.000744	CcSEcCtD
Didanosine—Vomiting—Vincristine—kidney cancer	8.11e-05	0.000741	CcSEcCtD
Didanosine—Rash—Vincristine—kidney cancer	8.05e-05	0.000735	CcSEcCtD
Didanosine—Dermatitis—Vincristine—kidney cancer	8.04e-05	0.000734	CcSEcCtD
Didanosine—Abdominal pain—Paclitaxel—kidney cancer	8.01e-05	0.000732	CcSEcCtD
Didanosine—Body temperature increased—Paclitaxel—kidney cancer	8.01e-05	0.000732	CcSEcCtD
Didanosine—Headache—Vincristine—kidney cancer	8e-05	0.00073	CcSEcCtD
Didanosine—PNP—Metabolism—SCARB1—kidney cancer	7.99e-05	0.00264	CbGpPWpGaD
Didanosine—Hepatobiliary disease—Doxorubicin—kidney cancer	7.95e-05	0.000726	CcSEcCtD
Didanosine—Anorexia—Capecitabine—kidney cancer	7.93e-05	0.000724	CcSEcCtD
Didanosine—PNP—Metabolism—PTGS1—kidney cancer	7.91e-05	0.00261	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.87e-05	0.0026	CbGpPWpGaD
Didanosine—Agranulocytosis—Doxorubicin—kidney cancer	7.85e-05	0.000716	CcSEcCtD
Didanosine—PNP—Metabolism—PSMD7—kidney cancer	7.76e-05	0.00256	CbGpPWpGaD
Didanosine—Vomiting—Gemcitabine—kidney cancer	7.7e-05	0.000703	CcSEcCtD
Didanosine—Rash—Gemcitabine—kidney cancer	7.63e-05	0.000697	CcSEcCtD
Didanosine—Dermatitis—Gemcitabine—kidney cancer	7.63e-05	0.000696	CcSEcCtD
Didanosine—Headache—Gemcitabine—kidney cancer	7.58e-05	0.000692	CcSEcCtD
Didanosine—Nausea—Vincristine—kidney cancer	7.58e-05	0.000692	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.58e-05	0.000692	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—kidney cancer	7.55e-05	0.000689	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—kidney cancer	7.51e-05	0.000686	CcSEcCtD
Didanosine—Paraesthesia—Capecitabine—kidney cancer	7.47e-05	0.000682	CcSEcCtD
Didanosine—Hypersensitivity—Paclitaxel—kidney cancer	7.47e-05	0.000682	CcSEcCtD
Didanosine—PNP—Metabolism—BCHE—kidney cancer	7.35e-05	0.00243	CbGpPWpGaD
Didanosine—Dyspepsia—Capecitabine—kidney cancer	7.32e-05	0.000668	CcSEcCtD
Didanosine—Asthenia—Paclitaxel—kidney cancer	7.27e-05	0.000664	CcSEcCtD
Didanosine—PNP—Metabolism—SLC5A5—kidney cancer	7.26e-05	0.0024	CbGpPWpGaD
Didanosine—Decreased appetite—Capecitabine—kidney cancer	7.23e-05	0.00066	CcSEcCtD
Didanosine—Nausea—Gemcitabine—kidney cancer	7.19e-05	0.000656	CcSEcCtD
Didanosine—Pruritus—Paclitaxel—kidney cancer	7.17e-05	0.000655	CcSEcCtD
Didanosine—Pain—Capecitabine—kidney cancer	7.11e-05	0.000649	CcSEcCtD
Didanosine—PNP—Metabolism—SLC2A1—kidney cancer	7.01e-05	0.00231	CbGpPWpGaD
Didanosine—Diarrhoea—Paclitaxel—kidney cancer	6.94e-05	0.000633	CcSEcCtD
Didanosine—Gastrointestinal pain—Capecitabine—kidney cancer	6.8e-05	0.000621	CcSEcCtD
Didanosine—Chills—Doxorubicin—kidney cancer	6.77e-05	0.000618	CcSEcCtD
Didanosine—Alopecia—Doxorubicin—kidney cancer	6.67e-05	0.000609	CcSEcCtD
Didanosine—Body temperature increased—Capecitabine—kidney cancer	6.58e-05	0.0006	CcSEcCtD
Didanosine—Abdominal pain—Capecitabine—kidney cancer	6.58e-05	0.0006	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—kidney cancer	6.47e-05	0.000591	CcSEcCtD
Didanosine—Vomiting—Paclitaxel—kidney cancer	6.45e-05	0.000588	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	6.41e-05	0.00211	CbGpPWpGaD
Didanosine—Rash—Paclitaxel—kidney cancer	6.39e-05	0.000583	CcSEcCtD
Didanosine—Dermatitis—Paclitaxel—kidney cancer	6.39e-05	0.000583	CcSEcCtD
Didanosine—Headache—Paclitaxel—kidney cancer	6.35e-05	0.00058	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.21e-05	0.00205	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	6.19e-05	0.00204	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.17e-05	0.00204	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.17e-05	0.00204	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.17e-05	0.00204	CbGpPWpGaD
Didanosine—Hypersensitivity—Capecitabine—kidney cancer	6.13e-05	0.000559	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—kidney cancer	6.07e-05	0.000554	CcSEcCtD
Didanosine—Nausea—Paclitaxel—kidney cancer	6.02e-05	0.00055	CcSEcCtD
Didanosine—Asthenia—Capecitabine—kidney cancer	5.97e-05	0.000545	CcSEcCtD
Didanosine—Malaise—Doxorubicin—kidney cancer	5.92e-05	0.000541	CcSEcCtD
Didanosine—Pruritus—Capecitabine—kidney cancer	5.89e-05	0.000537	CcSEcCtD
Didanosine—Leukopenia—Doxorubicin—kidney cancer	5.88e-05	0.000537	CcSEcCtD
Didanosine—PNP—Metabolism—GSTP1—kidney cancer	5.85e-05	0.00193	CbGpPWpGaD
Didanosine—Diarrhoea—Capecitabine—kidney cancer	5.69e-05	0.00052	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—kidney cancer	5.59e-05	0.000511	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—kidney cancer	5.59e-05	0.000511	CcSEcCtD
Didanosine—PNP—Metabolism—ABCB1—kidney cancer	5.54e-05	0.00183	CbGpPWpGaD
Didanosine—Discomfort—Doxorubicin—kidney cancer	5.53e-05	0.000505	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—kidney cancer	5.47e-05	0.000499	CcSEcCtD
Didanosine—PNP—Metabolism—GSTM1—kidney cancer	5.38e-05	0.00177	CbGpPWpGaD
Didanosine—Anaphylactic shock—Doxorubicin—kidney cancer	5.36e-05	0.000489	CcSEcCtD
Didanosine—Infection—Doxorubicin—kidney cancer	5.33e-05	0.000486	CcSEcCtD
Didanosine—Vomiting—Capecitabine—kidney cancer	5.29e-05	0.000483	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—kidney cancer	5.25e-05	0.000479	CcSEcCtD
Didanosine—Rash—Capecitabine—kidney cancer	5.25e-05	0.000479	CcSEcCtD
Didanosine—Dermatitis—Capecitabine—kidney cancer	5.24e-05	0.000478	CcSEcCtD
Didanosine—Headache—Capecitabine—kidney cancer	5.21e-05	0.000476	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—kidney cancer	5.11e-05	0.000467	CcSEcCtD
Didanosine—PNP—Metabolism—CYP1A1—kidney cancer	5.1e-05	0.00168	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.07e-05	0.00167	CbGpPWpGaD
Didanosine—Nausea—Capecitabine—kidney cancer	4.94e-05	0.000451	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.89e-05	0.000446	CcSEcCtD
Didanosine—Paraesthesia—Doxorubicin—kidney cancer	4.81e-05	0.00044	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—kidney cancer	4.72e-05	0.000431	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—kidney cancer	4.66e-05	0.000426	CcSEcCtD
Didanosine—Pain—Doxorubicin—kidney cancer	4.59e-05	0.000419	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.38e-05	0.0004	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—kidney cancer	4.24e-05	0.000387	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—kidney cancer	4.24e-05	0.000387	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—kidney cancer	3.95e-05	0.000361	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—kidney cancer	3.85e-05	0.000351	CcSEcCtD
Didanosine—PNP—Metabolism—POMC—kidney cancer	3.8e-05	0.00125	CbGpPWpGaD
Didanosine—Pruritus—Doxorubicin—kidney cancer	3.79e-05	0.000346	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—kidney cancer	3.67e-05	0.000335	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.51e-05	0.00116	CbGpPWpGaD
Didanosine—Vomiting—Doxorubicin—kidney cancer	3.41e-05	0.000311	CcSEcCtD
Didanosine—Rash—Doxorubicin—kidney cancer	3.38e-05	0.000309	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—kidney cancer	3.38e-05	0.000308	CcSEcCtD
Didanosine—Headache—Doxorubicin—kidney cancer	3.36e-05	0.000307	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.26e-05	0.00107	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—kidney cancer	3.19e-05	0.000291	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.14e-05	0.00104	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS2—kidney cancer	3.03e-05	0.001	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTEN—kidney cancer	2.64e-05	0.000872	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.48e-05	0.000819	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3CA—kidney cancer	1.86e-05	0.000615	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.4e-05	0.000464	CbGpPWpGaD
